Related Experiment Video
Updated: Aug 29, 2026

Three-Dimensional (3D) Tumor Spheroid Invasion Assay
Published on: May 1, 2015
Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer
József Tímár1, Károly Lapis, József Dudás
1Department of Tumor Progression, National Institute of Oncology, Budapest, Hungary. jtimar@oncol.hu
Abstract:
Understanding the details of the molecular mechanism of tumor dissemination revealed that several proteoglycan species are involved in the process but their role can be described as Janus-faced. One level of proteoglycan alterations is at the expression of their genes coding for the core protein. Characteristically, in progressing tumors two patterns emerged: loss or neoexpression of surface proteoglycans (PG) depending on the initial expression pattern of the cell type of origin. The situation is similarly complex concerning the changes of glycosaminoglycan (GAG) of the PG during tumor progression. This is due to the fact that the majority of PGs involved is hybrid molecule meaning that their core protein can be glycanated both with chondroitin and heparan sulfate. However, such an alteration in glycanation of PG may fundamentally change the function of the molecule, especially the one operating at the cell surface. Among the extracellular PGs, decorin emerged as inhibitor of progression while perlecan as a promoter of the process. Analysis of the available data indicate that during metastatization tumor cells must express at least one cell surface HSPG species from the syndecan-glypican-CD44v3 group. Furthermore, the HS-chain of these proteoglycan(s) carry important molecular signatures (suphution or epimerization patterns). Experimental data suggest that tumor cell surface heparan sulfate (PG) may provide a target for specific anti-metastatic interventions.
Insights
Proteoglycans (PG) play a dual role in tumor spread, with altered gene expression and glycosaminoglycan (GAG) modifications influencing cancer progression. Targeting cell surface heparan sulfate (HS) proteoglycans (HSPG) offers a potential anti-metastatic strategy.
Area of Science:
- Molecular biology
- Cancer research
- Biochemistry
Background:
- Tumor dissemination involves complex molecular mechanisms.
- Proteoglycans (PG) are implicated in tumor progression but exhibit dual roles.
- Alterations in PG core protein expression and glycosaminoglycan (GAG) side chains are observed in cancers.
Purpose of the Study:
- To elucidate the Janus-faced role of proteoglycans in tumor dissemination.
- To investigate the impact of altered PG expression and GAG modifications on cancer progression.
- To identify potential therapeutic targets for anti-metastatic interventions.
Main Methods:
- Analysis of proteoglycan gene expression patterns in tumors.
- Characterization of glycosaminoglycan (GAG) modifications in proteoglycans.
- Evaluation of specific proteoglycans (decorin, perlecan) in tumor progression.
- Identification of cell surface heparan sulfate proteoglycan (HSPG) groups involved in metastasis.
Main Results:
- Tumor progression is associated with either loss or neoexpression of surface PGs.
- Hybrid PGs with chondroitin and heparan sulfate GAGs show altered functions.
- Decorin inhibits, while perlecan promotes tumor progression.
- Metastatic tumor cells require specific cell surface HSPG species (syndecan, glypican, CD44v3).
- Heparan sulfate (HS) chains on HSPGs contain molecular signatures influencing metastasis.
Conclusions:
- Proteoglycan alterations, including GAG modifications, are critical in tumor dissemination.
- Specific cell surface HSPGs and their HS-chain structures are essential for metastasis.
- Tumor cell surface heparan sulfate (PG) presents a promising target for anti-metastatic therapies.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Proteoglycans
Matrix Proteoglycans and Glycoproteins
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment

